Gut Microbiome that Influence Efficacy of Cancer Immunotherapy
Drugs that boost the immune system have revolutionized immunotherapy for certain cancers. However, only 35 percent of patients with melanoma benefit from such drugs. Specific strains of bacteria that naturally dwell in the intestines can improve the response to immunotherapy for patients being treated for advanced melanoma, finds a study conducted by a research team at the University of Chicago Medicine.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer